Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Manasita, Tanya"'
Autor:
Nitichen Kittiratchakool, Disorn Kulpokin, Chonticha Chanjam, Soamarat Vilaiyuk, Sirirat Charuvanij, Gun Phongsamart, Parichat Khaosut, Manasita Tanya, Ratanavadee Nanagara, Sira Nantapaisarn, Pattara Leelahavarong
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
Objectives This study aimed to analyse the cost–utility and budget impact of adding tocilizumab to the standard treatment for patients with refractory systemic juvenile idiopathic arthritis (sJIA) in Thailand.Design Economic evaluation using a deci
Externí odkaz:
https://doaj.org/article/8ee604e121e544749921b3cf4375098a
Publikováno v:
Clinical Rheumatology. 40:2339-2349
To assess short- and long-term outcomes and predictors of juvenile idiopathic arthritis (JIA) children treated with contemporary therapy and compare those with reports elsewhere. Children with JIA were recruited from our web-based REgistry for Childh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a189409be53f219e519e83dd4da2f79
https://doi.org/10.1007/s10067-020-05520-7
https://doi.org/10.1007/s10067-020-05520-7
Autor:
Kai Liang, Teh, Manasita, Tanya, Lena, Das, Sook Fun, Hoh, Xiaocong, Gao, Thaschawee, Arkachaisri
Publikováno v:
Clinical rheumatology. 40(6)
To assess short- and long-term outcomes and predictors of juvenile idiopathic arthritis (JIA) children treated with contemporary therapy and compare those with reports elsewhere.Children with JIA were recruited from our web-based REgistry for Childho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d3a829d64a2469fecafa67732cd73b14
https://pubmed.ncbi.nlm.nih.gov/33236179
https://pubmed.ncbi.nlm.nih.gov/33236179
Publikováno v:
Saturday, 15 June 2019.
Background: JIA remains one of the most common rheumatic diseases afflicted children in SE Asia1. Despite the improvement in our treatment, outcomes of children treated with current therapy are unknown. Objectives: To describe the clinical outcomes o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80eedd2a5c469b28c5c1beef50ace199
https://doi.org/10.1136/annrheumdis-2019-eular.4002
https://doi.org/10.1136/annrheumdis-2019-eular.4002
Autor:
Ratanavadee Nanagara, Nitichen Kittiratchakool, Parichat Khaosut, Soamarat Vilaiyuk, Sirirat Charuvanij, Sira Nantapaisarn, Pattara Leelahavarong, Manasita Tanya, Gun Phongsamart, Chonticha Chanjam, Disorn Kulpokin
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 9 (2020)
BMJ Open, Vol 10, Iss 9 (2020)
ObjectivesThis study aimed to analyse the cost–utility and budget impact of adding tocilizumab to the standard treatment for patients with refractory systemic juvenile idiopathic arthritis (sJIA) in Thailand.DesignEconomic evaluation using a decisi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f8a44b91e86984f970888a6700ec4cf
https://doi.org/10.1136/bmjopen-2020-037588
https://doi.org/10.1136/bmjopen-2020-037588
Autor:
Justin Hung Tiong Tan, Kai Liang Teh, Manasita Tanya, S. Yoo, T.H. Tan, Thaschawee Arkachaisri, J.T.L. Choo, Lena Das
Publikováno v:
Annals of the Rheumatic Diseases. 75:767.2-767
Background Kawasaki Disease (KD) is one of the most common systemic vasculitidies in children today. IVIG is the mainstay of treatment, however, about 1/5 of patients do not respond (Teraguchi) resulting in an increased risk of Coronary Artery Abnorm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6beb2d6af4b33ee2905b6ce4d721f821
https://doi.org/10.1136/annrheumdis-2016-eular.5617
https://doi.org/10.1136/annrheumdis-2016-eular.5617